throbber

`
`Br. J. Cancer (I994). 70. 228—232 © Macmillan Press Ltd.. 1994
`
`Effects of inoculation site and Matrigel on growth and metastasis of
`human breast cancer cells
`
`L. Bao, Y. Matsumura, D. Baban, Y. Sun & D. Tarin
`
`Nuflield Department of Pathology. University of Oxford, John Radclifle Hospital, Headington, Oxford, 0X3 9DL', UK.
`
`Summary The co-injection of extracellular matrix components. such as Matrigel. with human tumour cells
`into nude mice has been reported to facilitate tumour formation and growth. but it is unknown whether such
`components exert similar effects on tumour progression and metastasis. Metastatic behaviour is known to be
`enhanced when tumour cells are implanted orthotopically. and it is inferred that full and eflicient expression of
`this phenotype may involve some interactions with local connective tissue matrix. It was therefore decided to
`investigate whether manipulation of the mesenchymal environment by co-injection of extracellular matrix
`components. in the form of Matrigel. with human brcast cancer cells into orthotopic or ectopic sites could
`augment their metastatic performance, as well as their growth at the site of inoculation. Standard aliquots of
`10‘ cells of the polyclonal human breast carcinoma cell line MDA-MB—435. and of four clonal cell lines. two
`metastatic and two non-metastatic derived from it, were injected with and without Matrigel. orthotopically or
`subcutaneously into nude mice. The latent period of tumour formation at the inoculation site as well as final
`tumour size and metastatic performance at autopsy. 140 days after inoculation. were then assessed. The
`prevalence of metastasis of the parent. polyclonal, cell line and of its metastatic clones was increased if the cell
`inoculum was mixed with Matrigel. Non-metastatic clones were not induced to become metastatic by this
`trcatment, but local
`tumour growth at
`the site of inoculation was enhanwd in all experimental groups
`receiving Matrigel. Orthotopic inoculation acted synergistically with Matrigel
`to maximise both tumour
`growth and metastatic behaviour. The composition of the local extracellular matrix at the site of tumour
`growth influenwd expression of the memmtic phenotype by cells which are constitutionally capable of this
`behaviour. but did not induce it in ones which are not. Previous reports that local tumour growth is facilitated
`by enrichment of the mesenchymal matrix are confirmed. The mechanisms by which such effects are exerted
`are worthy of study. to ascertain whether they might be subject to clinical manipulation designed to retard
`tumour growth and dissemination.
`
`
`
`The discovery that mutant athymic nude mice do not reject
`heterotransplants of human tumour tissue (Rygaard & Povl-
`sen.
`1969) provided new opportunities
`for experimental
`studies on human tumours,
`including the analysis of their
`metastatic properties. However, several subsequent reports
`noted that
`the prevalence of tumour formation by xeno—
`grafted fresh primary human tumour fragments in nude mice
`is low, approximately 30% (Sharkey & Fogh, 1984), al-
`though the ‘take rate’ with passaged tumour cell lines (Fogh
`et a1., 1977) and with tissues from metastases (Sharkey &
`Fogh, 1984)
`is about double this. Also, many tumour
`implants and cell lines. including those derived from highly
`malignant human cancers, fail to form metastases in adult
`nude mice, even if they do grow at the site of implantation
`(Sharkey & Fogh, 1978; Fidler, 1986) and the animals are
`expensive, delicate and highly susceptible to infection. These
`difficulties have impeded and delayed extensive use of nude
`mouse xenografts in research on mechanisms of human
`tumour metastasis. Even so, the goal of being able to study
`this event
`in a living host has motivated investigators to
`persist in efiorts to induce human tumour cells to re-enact
`the metastatic process in emerimental animals. Variables that
`have been found to afiect whether metastasis occurs include
`the health and housing conditions of the mice (Sharkey &
`Fogh, 1978; Neulat-Duga er a1.. 1984; Fidler, 1986), the level
`of natural killer (NK)-cell activity, age of the host (Fidler.
`1986) and the route of tumour cell inoculation (Kozlowski et
`(11.. I984; Giavazzi et a1.. 1986). in addition to the intrinsic
`properties of the tumours under investigation.
`Of
`the
`several human tumour
`types now becoming
`available for the study of metastasis in the nude mouse. one
`of the most interesting for future study is the MDA-MB—435
`cell
`line isolated from a pleural efiusion in a patient with
`brcast cancer
`(Caillou e!
`(11.. 1978). Price et
`a1.
`(1990)
`reported that orthotopic implantation of cells of this line into
`the mammary fat pad (mfp) of nude mice could enhance its
`
`Correspondence: D. Tarin
`Received ll October 1993: and in revised form 14 March 1994.
`
`tumorigenicity in this host. and these tumours were found to
`be more metastatic than those formed after subcutaneous
`inoculation. These findings confirm and extend similar obser-
`vations.
`reported in recent years (Bresalier e!
`(1].. 1987:
`Morikawa et al..
`I988). with colon carcinoma cell
`lines.
`Tumours formed by these cell
`lines following intramural
`injection in the colon are more metastatic than those result-
`ing from subcutaneous inoculation. An orthotopic microen-
`vironment evidently encourages tumour cells to express the
`malignant phenotype (See also Fidler. 1990). This raises the
`question of how such an effect might be mediated and what
`it might signify.
`In vivo. carcinoma cells are surrounded by cellular connec-
`tive tissue composed of fibroblasts. endothelium and other
`cells in a dense network of extracellular matrix proteins
`which provides them all with a three-dimensional structural
`framework and influences their behaviour. The interdepen-
`dency of these elements is illustrated by some recent experi-
`mental observations. For example. Fabra er
`a1.
`(1992)
`demonstrated that highly metastatic KMIZSM colon car-
`cinoma cells co-cuitivated with fibroblasts from the colon are
`able to demonstrate an invasive phenotype and produce type
`IV collagenase, whereas the same line cultivated with skin
`fibroblasts can not. These carcinoma cells are metastatic
`from tumours formed after intramural
`inoculation in the
`colon but not after subcutaneous inoculation.
`tumour
`Recent
`investigations have also indicated that
`growth and behaviour is influean by non-cellular elements
`of the adjacent connective tissue matrix. In these studies it
`was found that a reconstituted basement membrane deriva-
`tive termed Matrigel. composed mainly of laminin. collagen
`type IV. heparan sulphate proteoglycan and entactin. greatly
`enhances the tumorigenicity of various malignant cells.
`in-
`cluding small-cell
`lung carcinomas. Blo—FIO melanoma.
`human submandibular A253 carcinoma. prostate carcinoma
`cell lines and primary colon carcinoma cells (Fridman er al..
`1990. 1991; Pretlow et a1.. 1991) Tumour cells premixed with
`Matrigel and then injected into athymic mice consistently
`produwd tumours which grew faster and became much
`larger than tumours induced by the same cells injected with-
`Genentech 2093
`
`Hospira v. Genentech
`IPR2017-00737
`
`Genentech 2093
`Hospira v. Genentech
`IPR2017-00737
`
`

`

`out Matrigel. Fridman er al. (1992) also showed that non-
`transforrned and non-tumorigenic NIH-3T3 cells
`formed
`lowlly invasive and highly vascularised tumours when co-
`injected with Matrigel into athymic mice. The cells isolated
`from the Matrigel-induwd tumours exhibited cellular charaCo
`teristics similar
`to that observed in NIH-3T3 cells after
`malignant transformation and were eapable of forming pul-
`monary tumour colonies when injected i.v. These studies
`suggested that
`interaction of premalignant NIH-3T3 cells
`with extracellular matrix components can contribute to the
`process of tumour progression. In the current experiments we
`studied whether Matrigel would affect the growth of tumours
`formed in nude mice by human breast mreinoma cell lines
`with different metastatic potentials. We also investigated the
`efiect of this material on the incidence of metastasis from
`tumours formed by these lines after injection subcutaneously
`or into the mfp. The results showed that Matrigel could
`enhance the growth of tumours, in both sites, regardless of
`the degree of malignancy of the cell line. Matrigel could also
`increase
`the incidence of spontaneous metastasis
`from
`tumours formed by cell clones of the MDA-MB—435 line
`which have some intrinsic metastatic eapability, but did not
`induce any metastatic behaviour in clones which had no such
`inherent tendency.
`
`Maharishi-(1m
`
`Animals
`
`Athymic nude mice (MFlNu) were obtained from the brwd-
`ing facility at the John Radclifl‘e Hospital, Oxford, UK. Mice
`were injected with tumour cells when 6—8 weeks old and
`were kept in filter-top boxes in an isolated colony. Care of
`animals in this work was conducted according to United
`Kingdom Home Oflice and Oxford University regulations.
`
`Cell culture The polyclonal human breast carcinoma cell
`line MDA—MB—435 and the clonal cell lines C1, C2, C3 and
`C4 we derived from it by a limiting dilution technique were
`maintained in Dulbecco’s modified Eagle medium (DMEM)
`supplemented with
`5% newborn calf
`serum,
`sodium
`pyruvate, L-glutamine (ZmM), non-essential amino acid and
`2 x vitamin solution (Gibco). The cultures were incubated at
`37‘C in a humidified atmosphere of 5% mrbon dioxide—95%
`air. Tumour cells were harvested by washing the monolayer
`with phosphate-buffered saline (PBS)
`followed by brief
`incubation in 0.25% trypsin—0.02% EDTA at 37'C. The
`cells were then washed by centrifugation and resuspended in
`DMEM in preparation for inoculation. Clones C1 to C4
`were chosen for use in this study on the basis of earlier
`assays of their metastatic capabilities (see below) when
`injected suspended in culture medium alone.
`
`Matrigel
`
`Matrigel was extracted from fresh pieces of the mouse Eng—
`lebreth-Holm—Swarm (El-IS)
`tumour as described previ-
`ously (Kleinman er al., 1986, 1990). Briefly, 100g of the
`tumour tissue was washed in chilled 3.4M sodium chloride
`and 0.05 M Tris—HCI, pH 7.4, containing 5 mg ml‘I protease
`inhibitor, and homogenised in 150ml of 2M urea with
`0.05 M Tris—HCl, pH 7.4. The sample was left stirring over-
`night at 4°C and was then centrifuged at 10,000 g for 30 min.
`The supernatant was collected and the solid residue was
`washed once with the same volume of buffer. Then the
`supernatant and wash were combined, dialysed against
`0.15 M sodium chloride in 0.05 M Tris-HCI, pH 7.4 (TBS),
`for 6h, and subsequently against PBS and DMEM and
`finally centrifuged at 15,000 r.p.m. for 20 min to remove any
`residual
`insoluble material. The supernatant fraction was
`stored at —20°C in small aliquots until used in the
`experiments.
`
`MATRIGEL ENHANCEMENT OF METASTASIS
`
`229
`
`Tumour cell inoculation
`
`The tumour cells were harvested and resuspended in cold
`DMEM, mixed with an equal volume of cold (4'C) liquid
`Matrigel and immediately injected s.c. or in the mfp. During
`inoculation the stock cell suspension in Matrigel was kept
`chilled in an ice bucket to ensure that it did not begin to gel,
`as the extract readily does at 37'C. Mice in control groups
`were given subcutaneous and mfp injections of 10‘ tumour
`cells in 0.1 ml of DMEM with no Matrigel. For inoculation
`into the mfp the mice were anaesthetised with Metofane and
`a 5mm incision was made in the skin over the flank. The
`
`mfp was exposed and 0.1 ml of fluid containing 106 cells was
`injected into the tissue of the gland through a 27 gauge
`needle. By exposing the fat pad, we were able to ensure that
`the cells were injected into the tissue and not into the s.c.
`space. Tumour cells were injected s.c. remote from the mfp,
`in separate groups of animals.
`
`Twnorigenicity and metastasis in vivo
`
`The tumorigenicity and spontaneous metastatic eapability of
`the cells were observed following subcutaneous and mfp
`injections of l x 10‘ cells in 0.1 ml of DMEM into the lower
`right hind flank of nude mice. The animals were monitored
`every 2—3 days for over 4 months for the presence of a
`grossly visible and palpable mass at the injection site. Loeal
`primary tumour growth was evaluated by measurement of
`mean latent period and of eventual size at 140 days after
`injection. Autopsy was performed at 140 days, or sooner if
`the tumours were large or the host was ill or distreswd.
`Metastasis formation was studied by macroscopic examina-
`tion of all major organs of inoculated mice for secondary
`tumours and by histologieal examination of major organs
`and lymph nodes. The prevalence of metastasis in each batch
`of inoculated animals and the numbers of surface deposits
`seen in the lungs and other organs of each animal were
`recorded. Tissues were fixed in 10% neutral formalin and
`paraflin embedded for histologiml confirmation of macro-
`scopic observations.
`
`Remlts
`
`Eflect of Matrigel on metastasis
`
`Spontaneous metastasis from tumours formed at the site of
`inoculation by metastatic cell
`lines was reproducibly in-
`creased by Matrigel and more so by orthotopic inoculation
`(Table 1). The details are as follows:
`
`Polyclonal parent MDA-MB-435 line The prevalence of
`metastasis from tumours formed by the polyclonal MDA-
`MB—435 cell line was greater when the original inoculum was
`premixed with Matrigel before injection s.c. or in the mfp
`(Table I).
`
`lines Cl and C2
`Clonal cell lines Via the s.c. route, cell
`without Matrigel prodmd visible lung metastases in 21%
`(C1) and 37% (C2) of injected mice, respectively, and extra-
`pulmonary (hepatic) metastases in only one mouse (C2).
`When premixed with Matrigel these cell
`lines exhibited in-
`creased metastasis to the lung and to extrapulmonary sites.
`The prevalence of pulmonary metastasis in these groups of
`animals was 47% (Cl) and 56% (C2) respectively. C2 cells
`also produwd metastases in the liver, spleen and kidney (3 of
`16 mice,
`i.e. 19%), but Cl did not. Via the mfp route,
`without Matrigel, clone C l produmd lung metastases in 44%
`and C2 in 53% of mice. Only clone C2 produced a solitary
`extrapulmonary metastasis, and this was in the liver. Meta-
`static properties were incrmsed when cells were premixed
`with Matrigel and inoculated in this site. Many mice de-
`veloped easily visible lung colonies by 4 months. C1 pro-
`duwd pulmonary metastases in 60% of mice and C2 in 79%.
`C1 did not produce any extrapulmonary deposits, but with
`
`

`

`230
`
`L. BAO et al.
`
`Table 1 Effect of Matrigel on metastasis of MDA-MBA-435 cell
`
`lines
`
`Prevalence of
`pulmonary metastasir‘ (%)
`
`
`
` Cell line Injection route No Matrigel With Matrigel Number of colonies” P‘
`
`
`
`
`
`MDA-MB435 poly
`
`MDA-MB—435 C1
`
`MDA-MB-435 C2
`
`MDA-MB—43S C3
`
`MDA-MB—435 C4
`
`s.c.
`mfp
`
`s.c.
`mfp
`
`s.c.
`mfp
`
`s.c.
`mfp
`
`s.c.
`ml'p
`
`6/29 (21)
`7/17 (41)
`
`5/23 (21)
`7/16 (44)
`
`9/24 (37)
`8/15 (53)
`
`0/19
`0/15
`
`0/12
`0/13
`
`12/23 (52)
`12/18 (67)
`
`7/15 (47)
`12/20 (60)
`
`9/16 (56)
`15/19 (79)
`
`0/13
`0/14
`
`0/17
`1/17 (6)
`
`1 (0-3)
`1
`(0—5)
`
`2 (0—4)
`3 (0—10)
`
`<005
`'
`
`2 (0—5)
`2 (075)
`
`2 (0—8)
`3 (0—9)
`
`2 (0—4)
`2 (0—6)
`
`2 (0—14)
`4 (0—19)
`
`0
`0
`
`0
`0
`
`0
`0
`
`0
`0 (0—2)
`
`<005
`‘
`
`<005
`‘
`
`NS
`
`NS
`
`'Mice with metastases. Mice with tumours.
`
`t’Median and range. cSignificance tested with 2 x 2 12 test.
`
`8
`
`20
`
`O
`
`.a O
`
`E .
`
`5.
`'5
`‘5
`Ea
`‘6
`SO
`
`E3ca
`
`:o2
`
`Fig-e 1 Effect of Matrigel on the growth of tumours formed by
`polyclonal MDA-MB—435 cell
`lines. - . Without Matrigel;
`, with Matrigel.
`
`C2 metastases were seen in the liver, spleen or kidneys in
`26% of mice.
`Cell line C3 did not form any metastases via either the s.c.
`or the mfp route. Though cells premixed with Matrigel pro-
`duwd earlier and larger tumours in both s.c. and mfp sites,
`no lung or other deposits could be found in any mice. None
`was found in animals injected by either route without Mat-
`rigel. Similarly, clone C4 produced only two pulmonary de-
`posits in a single mouse. This was injected in the mfp with
`cells mixed with Matrigel. None of the remaining animals
`injected with these cells, with or without this matrix material
`in either site, had metastases in any organ.
`
`Eflect of Matrigel on the growth of twnours formed by
`polyclonal MDA-MB—435 cells
`
`l x 10‘
`tumour growth When aliquots of
`Subcutaneous
`polyclonal MDA-MB—435 cells premixed with liquid Matrigel
`or suspended in culture medium alone were injected into
`nude mice by either s.c. or mfp routes, all animals developed
`tumours. However,
`the growth of s.c.
`tumours formed by
`cells in culture medium alone, without Matrigel, was slowest.
`No visible tumours were apparent within a period of 20 days.
`The mean time required for a tumour to reach a size of 1 cm
`(latency period) was 135 days (i 10 days). The most slowly
`growing of these tumours reached a size of 10.4mm when
`the animal was killed 140 days after inoculation. Tumours
`appeared sooner and mched larger
`final dimensions in
`animals receiving cells premixed with Matrigel subcutane-
`ously. The latency period was 120 days (it 8 days).
`
`in culture medium
`Mammary tumour growth The cells
`alone,
`injected into mfp, produwd rumours with similar
`growth to s.c. tumours formed by cells mixed with Matrigel.
`The fastest growing tumours were found in the mice injected
`in the mfp with cells premixed with Matrigel (Figure 1).
`These were visible 20 days after inoculation. The latency
`period to 1 cm diameter was 80 days (i 5 days). The largest
`tumour found in this group had reached a diameter of
`29.9mm at 140 days after inoculation.
`
`Eflect of Matrigel on the growth of tumours formed by
`MDA—MB-435 cell clones with dzflerent metastatic potentials
`Four clonal cell lines derived from the parent MDA-MB—435
`line were selected to study the effect of Matrigel on the
`growth and behaviour of tumour cells with difierent meta-
`static potentials. Clones Cl and C2 were known from our
`previous assays to be metastatic via i.v. and s.c.
`routes.
`Conversely, clone C3 was completely non-metastatic by
`either i.v. or s.c. injection, and C4 produwd only two lung
`metastases in 1 out of 28 animals (3%) (Table I). The growth
`of tumours formed by cells premixed with Matrigel was
`faster than corresponding tumours formed by cells not mixed
`with Matrigel,
`in both s.c. and mfp sites (Figure 2). The
`
`8
`
`__
`SE
`°Ezo
`Ev
`35
`:0
`8810
`2%
`
`O
`
`8
`
`8
`
`O
`
`
`
`diameter(mm)
`
`
`
`
`
`Meanfinaltumour
`
`C3
`
`,
`/
`Z
`/
`%
`g
`%
`
`7/
`/
`Z
`/
`%
`g
`%
`

`
`Z
`%
`g
`%
`
`8
`
`'5...
`/
`% gs
`%
`E20
`/ 3v
`Z *25
`/ to
`% cE'°
`Z 3%
`Z 5
`
`8
`
`O
`O
`3 Mean
`
`finaltumour
`
`diameter(mm) 3
`t\\\\\\\\\\\\\\\\\\\\\\\\‘
`
`Fig-e 2 Effect of Matrigel on the growth of tumours formed by
`cloned (C 1-4) MDA-MB—435 cell lines. - , Without Matrigel;
`, with Matrigel.
`
`degree of enhancement judged by final tumour size seemed to
`be the same whether the tumours were formed by metastatic
`cell clones or by non-metastatic ones (data not shown). There
`was no evidence of correlation of growth enhancement with
`metastatic capability in these four cell clones tested.
`
`

`

`D'
`
`.
`
`Previous studies by other groups have established that when
`the reconstituted basement membrane material Matrigel
`is
`co-injected s.c. with various human and murine tumour cell
`lines or with freshly dissociated primary human tumour cells
`the prevalence and the growth rates of loeal primary tumours
`are increased (Fridman et al., 1990, 1991; Pretlow et al.,
`1991). In the present study we found that Matrigel facilitated
`not only the growth but also the metastasis of tumours
`formed by the human breast earcinoma line MDA—MB-435
`in nude mice and by some of the clones derived from it.
`From this body of data it is evident that a judicious choice of
`tumour
`cell
`line,
`site of
`inoculation and facilitatory,
`mesenchymally derived,
`tissue constituents can now enable
`an investigator reliably to observe and analyse the metastatic
`spread of human tumour cells in the body of the nude
`mouse.
`
`information available to
`there is insufficient
`At present,
`define the active components in Matrigel which affect tumour
`growth and metastasis formation. Laminin, the major consti-
`tuent of Matrigel, has been shown to accelerate the attach-
`ment, activation and growth of tumour cells (Fridman et al.,
`1990, 1991), and to increase tumour metastases when injected
`intravenously with B16F10 melanoma cells (Barsky et al.,
`1984; Terranova et al., 1984). However, laminin alone does
`not promote tumour growth as effectively as Matrigel in the
`s.c. site (Fridman et al., 1990). Collagen IV, entactin and
`heparan sulphate proteoglywn are also biologieally active
`and may contribute to the growth, adhesion, spreading and
`motility of tumour cells (Aumailley & Timpl, 1986; Clement
`et al., 1989; Chakravarti er al., 1990). Further experiments
`involving sequential addition of such components to laminin
`in the medium in which the inoculated cells are suspended
`could help to analyse which of these constituents of Matrigel
`mediates its facilitatory effects on metastasis. The physical
`consistency of Matrigel
`is also more viscous than that of
`culture medium, and this may make some contribution to its
`observed effects. It is possible that this inhibits scattering of
`tumour cells after inoculation and thereby promotes relevant
`interactions between themselves and with surrounding cells
`(see below).
`Recent studies with different human and murine tumour
`cell
`lines have shown that
`the site of inoculation ean
`influence whether distant metastases are formed (Ahlering er
`
`References
`
`AHLERING. T.E.. DUBEAU. L. & JONES. PA. (1987). A new in vivo
`model to study invasion and metastasis of human bladder ear-
`cinoma. Cancer Res, 47, 6660—6665.
`AUMAILLEY. M. & TIMPL. R. (1986). Attachment of cells to base-
`ment membrane
`collagen
`type
`IV.
`J. Cell Biol..
`103,
`1569—1575.
`BARSKY. S.H.. RAO. C.N.. WILLIAMS. J.E. & LIOTTA. LA. (1984).
`Laminin molecular domains which alter metastasis in a murine
`model. J. Clin. Invest, 74, 843—848.
`BRESALIER. R.S.. RAPER. S.E.. HUJANEN. E.S. & KIM, Y.S. (1987). A
`new animal model for hrnnan colon eancer metastasis. Int. J.
`Cancer, 39, 625—630.
`(1978). Long-term
`CAILLOU, R.. OLIVE M. & CRUCIGER. Q.VJ.
`human
`breast mrcinoma
`cell
`lines of metastatic
`origin:
`preliminary characterisation. In Vitro. 14, 911—915.
`CHAKRAVARTI. S.. TAM. M.F. & CHUNG. A.E. (I990). The basement
`membrane glycoprotein entactin promotes cell attachment and
`binds ealcium ions. J. Biol. Chem, 265, 10597—10603.
`CLEMENT. 3.. SEGUI-REAL. B.. HASSELL. J.R.. MARTIN. GR. &
`YAMADA. Y. (1989). Identification of a cell surface-binding pro-
`tein for the core protein of the basement membrane proteoglyean.
`J. Biol. Chem. 264, 12467—12471.
`FABRA. A.. NAKAJIMA. M.. BUCANA. CD. & FIDLER. U. (1992).
`Modulation of the invasive phenotype of human colon earcinoma
`cells by organ specific fibroblasts of nude mice. Diflerentiarion,
`52, 101—110.
`FIDLER, U. (1978). Tumor heterogeneity and the biology of eancer
`invasion and metastasis. Cancer Res, 38, 2651~2660.
`
`MATRIGEL ENHANCEMENT OF METASTASIS
`
`73]
`
`al., 1987; Bresalier et al., 1987; Morikawa et al., 1988; Price
`et al., 1990), although it is not clear how the loeal
`tissue
`environment exerts this effect. The present work confirms
`that the mfp is a more favourable site than the subcutis for
`the growth of mammary tumours (Miller et al., 1981; Price et
`al., 1990), and also for the expression of metastatic ability,
`there being a higher frequency of metastasis from the mfp
`tumours. Matrigel and mfp inoculation acted synergistimlly
`to facilitate all cell lines to produce larger tumours but did
`not induce the non-metastatic clones C3 and C4 to Mome
`metastatic, although the prevalence of metastasis by the
`parent
`line and by metastatic clones C1 and C2 was in-
`creased. Such findings indieate that pulmonary metastasis
`after
`inoculation, either
`s.c. or mfp, or with Matrigel,
`primarily depends on intrinsic properties of the tumour cells
`(Fidler, 1978; Tarin & Prince, 1979), but can be modulated
`by lowl microenvironmental factors.
`Recent
`results (Steeg et al., 1988; Hayle er al., 1993)
`indicate that metastatic events occur as a result of genetic
`disturbances which allow the inappropriate expression of
`genes that are silent in most cells, enabling the cells affected
`and their progeny to disseminate from the primary site. This
`new evidence suggests that metastasis may occur as a conse-
`quence either of failure of a negative regulatory event respon-
`sible for inhibiting inappropriate cell migration and distant
`colonisation, perhaps involving the 701123 gene (Steeg er al.,
`1988), or of the activation and up—regulation of a gene
`capable of dominantly conferring the phenotype (Hayle et
`al., 1993). In any event, once this balance has been disturbed,
`it appears that microenvironmental influences, such as the
`site of growth of the tumour cells or the constitution of the
`adjacent
`tissue matrix, ean accelerate tumour growth and
`dissemination. The mechanisms by which this effect is medi-
`ated deserve further investigation, to ascertain whether they
`might be susceptible to pharmacological hindrance, which
`could have the dual clinieal benefit of retarding the growth of
`secondary tumours as well as impeding further dissemina-
`tron.
`
`We wish to thank Dr J.E. Price for the gift of the MDA-MB—435 cell
`line and our colleague Mrs L. Summerville for valuable help with
`assembly of the manuscript. This work was partially supported by
`the Anthony Placito Fund for Medieal Research of Oxford Univer-
`sity.
`
`FlDLER. IJ. (1986). Rationale and methods for the use of nude mice
`to study the biology and therapy of human cancer metastasis.
`Cancer Metastasis Rein, 5, 29—49.
`FIDLER. IJ. (1990). Critieal factors in the biology of human eancer
`metastasis. Cancer Res, 50, 6130—6138.
`FOGH. 1.. FOGH. JM. & ORFEO, T. (1977). One hundred and twenty~
`seven cultured human tumour cell
`lines producing tumours in
`nude mice. J. Natl Cancer (ML, 59, 221—225.
`FRIDMAN. R., GIACCONE. G.. KANEMOTO, T., MARTIN, G.R., GAZ-
`DAR, A.F. & MUISHINE. IL.
`(1990). Rwonstituted basement
`membrane (Matrigel) and laminin ean enhance the tumorigenicity
`and the drug resistance of small cell lung carcinoma cell
`lines.
`Proc. Natl Acad. Sci. USA, 87, 6698—6702.
`FRIDMAN, K. KIBBEY. M.C., ROYCE, L.S., ZAIN, M., SWEENEY,
`T.M.. IICHA. D.L.. YANNELLI. 1.1L. MARTIN. GR. 3; KLEINMAN,
`H.K. (1991). Enhanwd tumor growth of both primary and estab-
`lished human and murine tumor cells in athymic mice after
`coinjection with Matrigel. J. Natl Cancer bun, 83, 769—775.
`FRIDMAN. R.. SWEENEY. T.M.. ZAIN, M.. MARTIN, G.R. & KLEIN-
`MAN. H.K. (1992). Malignant transformation of NIH-3T3 cells
`after subcutaneous co-injection with a reconstituted basement
`membrane (Matrigl). Int. J. Cancer, 51, 740—744.
`GIAVAZZI. R.. CAMPBELL, D.E.,
`JFSSU'P. J.M.. CLEARY. K. &
`FIDLER. IJ. (1986). Metastatic behavior of tumor cells isolated
`from primary and metastatic human colorectal earcinomas
`implanted in different sites in nude mice. Cancer Res. 46,
`1928—1933.
`
`

`

`2.32
`
`L. BAO er a].
`
`HAYLE, AJ., DARLING D.L, TAYLOR. A.K & TARIN, D. (1993)
`Transfection of metastatic capability with total gnomic DNA
`fromhmnanandmonsemetastatictmnourmfllines.
`Werethion, 54, 177- 189.
`KLEINMAN, ELK- MCGARVEY, M.L, HASSELL IR“ STAR, V.L.,
`CANNON, F.B., LAURIE, G.W. & MARTIN, GR. (1986). Basement
`membrane complexts with biological activity. Biochemistry, 5,
`312-318.
`KOZLOWSKI. J.M.. FIDLER. IJ., CAMPBELL. D.. XU. Z-L. KAIGHN.
`ME. & HART, LR. (1984). Metastatic behavior of human tumor
`wfllinesgrowninthemndemouse.€ancerker.,“,
`3522—3529.
`MILLER1 F.R.. MEDINA. D. & HEPPNER. CLH. (1981). Preferential
`growth of mammary tumors in intact mammary fatpads. Cancer
`Res., 41, 3863— 3867.
`MORIKAWA. K. WALKER. SWM “UP, 1M & FIDLER, IJ. (1988).
`Invivoselectionofhighlymetastaticoellsfromsurgialspecimens
`of difl'erent primary human colon carcinomas implanted into
`nude mice. Cancer Res., 48, 1943—1948.
`NEULAT—DUGA. I. Sl-I'EPPEL, A., MARTY. C, LACROUX, F_, POUR~
`RAT, 1., CAVERIVIERE l". & DEISOL, G. (1984). Metastasis of
`human tumour xenogmfts in nude mice. Invasion Metastasis, 4,
`2097224.
`
`PREI'LOW T.G DELMORO, C.M. DILLEY, G..G, SPADAFORA, CG.
`& FRI-711.091,“).
`(1991). Transplantation of human postatic
`carcinoma into nude mice
`in Matrigel. Cancer Res., 51,
`3814— 3817
`PRICE. J.,E. POLYZOS A. ZHANG, R.D. &DANIELS, LM. (19%).
`Tumorigenicity and metastasis of human breast carcinoma cell
`linesinnudemice. CancerRer, 50,717- 721.
`RYGAARD J. A POVLSEN, CO. (1969). Heterotransplantation of a
`human malignant tumour to nude mice. Acta Pathol. Microbiol.
`Sand, Tl, 758—760.
`SHARKEY, F.E. & FOGH, J. (1978). Metastasis of human tumours in
`athymic nude mice. Int. J. Cancer, 24, 733—738.
`SHARKEY, RF. 1 FOGH, J. (1984). Considerations in the use of nude
`mice for cancer research. Cancer Metastasis Rev., 3, 341—360.
`STEEG, PS., BEVIIACQUA, G., KOPPER. L, THORGEIRSON, U.P.,
`TALMADGE J.E., LIO'I'I'A. LA. & SOBEL, MI. (1988). Evident!
`for a novel gene asaeiated with low tumor metastatic potential.
`J. Natl Career Inst, D, fill—204.
`TARIN. D. & PRICE, HE. (1979). Metastatic colonization potential of
`primary tumour cells in mice. Br. J. Cancer, 39, 740—754.
`TERRANOVA, V.P., WILLIAMS. J.E., LIOTl'A, LA & MARTIN, G.K
`(1984). Modulation of the metastatic activity of melanoma cells
`by laminin and fibronectin. Science, 226, 982-985.
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket